Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Cardiothoracic Surgeons (EU)(?)

Council Members in this Study Group: 175

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
exforge true observance improvement associating two efficient blockbusters in the treatment of high blood pressure | 06-25-2007
Author: GLG Expert Contributor

Two lockbusters have been &associated in one pill to treat hypertension thees are the more efficient drugs today well tolerated with very few side effects 9 out of 10 patients are controlled observance will be improved control as well

A TRUE BREAKTHROUGH IN MEDICINE IF RESULTS ARE CONFIRMED | 06-21-2007
Author: GLG Expert Contributor

SO FAR THE REVASCULARISATIONS ARE SURGICAL OR THROUGH ANGIOPLASTY . IF THIS TRIAL HAPPENS TO STAND ITS PROMISES IT WILL REPLACE THE BYPASS OR ANGIOPLASTY BY A SIMPLE INTRA MUSCULAR INJECTION . IT WILL TREAT LIMB CORONARY ISCHEMIA SIMPLY . IT WILL HAVE SO TO DEMONSTRATE ITS INOCUITY IN CANCER DEVELOPMENT...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic
  • Government/Military Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Division Head
  • Physician - Director
  • Physician - Department Chair

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-10-12T13:45:19.273